Abstracts

Search by keyword or author name.

Filter

Study

Conference

Showing 807 abstracts.

Abacavir Weight-Band Dosing for Infants in the first 4 weeks of life

Conference

International Workshop on HIV Pediatrics

Study

P1106

Authors

Avy Violari, Mark Cotton, Ruth Mathiba, Andrew Wiznia, Renee Browning, Jack Moye, Bobbie Graham, Eric Decloedt, Helena Rabie, Mark Mirochnick, Timothy Cressey, IMPAACT P1106 Team, Adrie Bekker, Edmund Capparelli

Systemic inflammation in pregnant women with HIV: relationship with preterm delivery and HIV treatment regimen

Conference

International Workshop on HIV Pediatrics

Study

1077BF

Authors

Daya Moodley, Avy Violari, Lameck Chinula, Maxensia Owor, Amita Gupta, Judith S. Currier, Taha E Taha, Mary Glenn Fowler, PROMISE study team, Rupak Shivakoti, Mark Giganti, Michael Lederman, Rachel Ketchum, Sean Brummel, Daniela Moisi, Sufia Dadabhai

Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trial

Conference

International Workshop on HIV Pediatrics

Study

P1078

Authors

James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Phillippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 Study Team, Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati

Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023)

Conference

International Workshop on HIV Pediatrics

Study

IMPAACT 2023

Authors

Jeremiah Momper, Alicia Koblansky, Hardik Chandasana, Michael McKenna, Benjamin Johnston, Ceora Beijer, Hannah Small, Helty Adisetiyo, David Shapiro, Dean Soko, Jiajia Wang, Mariam Aziz, Evan Goldberg, Linda Aurpibul, Sarah Bradford, Suchada Ruenglerdpong, Iris Mustich, Keswadee Lapphra, Haley Brozik, Kathleen Powis, Dwight Yin, Maria Letícia Cruz, Ellen Townley, Ed Acosta, Kelly Colsh, Brookie Best, Andrea McMunn, Mark Mirochnick, Gretchen Buckler, Diana Clarke, Annie Buchanan

Safety and immunogenicity of Gardasil in HIV-infected children.

Conference

25th International Papillomavirus Conference

Study

P1047

Authors

Anna-Barbara Moscicki, Adriana Weinberg, Lin-Ye Song, Edward Handelsman, Julie A. Patterson, Alfred J. Saah, David Radley, Jennifer S. Read, Carlos A. Sattler, Myron Levin

Relationships between use of antipsychotics and changes in physical growth in children and adolescents with HIV.

Conference

American Psychiatric Association Annual Meeting

Authors

Suad Kapetanovic, Lisa Aaron, Grace Montepiedra, Patricia Sirois, Kathleen Malee, Patricia A. Garvie, Sharon L. Nichols, Betsy Kammerer, John J. Farley, James M. Oleske, Mark Mintz, Paige L. Williams

Preliminary Pharmacokinetics and Safety of a Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC) and Nevirapine (NVP) versus the Liquid Formulations in HIV-Infected Thai Children

Conference

10th Int'l Workshop on Clinical Pharmacology of HIV Therapy

Study

P1069

Authors

Tim Roy Cressey, Nirun Vanprapar, Edmund Capparelli, Wasana Prasitsuebsai, Linda Aurpibul, Petronella Muresan, Achara Eksaengsri, Elizabeth (Betsy) Smith, Kenneth McIntosh, Ram Yogev, Kulkanya Chokephaibulkit

Tenofovir pharmacokinetics across three tenofovir-based antiretroviral regimens in HIV-infected children and adolescents.

Conference

10th Int'l Workshop on Clinical Pharmacology of HIV Therapy

Authors

Jennifer R. King, Ram Yogev, Andrew A. Wiznia, Bobbie L. Graham, Vincent J. Carey, Paula Britto, Patrick Jean-Philippe, Eric K. Stets, Edward P. Acosta

Population pharmacokinetics of tenofovir in HIV-infected children and adolescents

Conference

10th Int'l Workshop on Clinical Pharmacology of HIV Therapy

Authors

Jennifer R. King

Lopinavir population pharmacokinetic model and dose simulation predicts rapid increase in exposure for HIV-infected infants initiating therapy at <6 months of age (IMPAACT/PACTG P1030)

Conference

16th Conference on Retroviruses & Opportunistic Infections

Study

P1030

Authors

M Nikanjam, Edmund Capparelli, Brian Robbins, Jorge Pinto, Ram Yogev, Carmelita Alvero, Paul Palumbo, Michael Hughes, John H. Rodman, Ellen Gould Chadwick

Abacavir Weight-Band Dosing for Infants in the first 4 weeks of life

Conference

Study

Authors

Systemic inflammation in pregnant women with HIV: relationship with preterm delivery and HIV treatment regimen

Conference

Study

Authors

Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trial

Conference

Study

Authors

Pharmacokinetics and Safety of Dolutegravir in Neonates Exposed to HIV-1 (IMPAACT 2023)

Conference

Study

Authors

Safety and immunogenicity of Gardasil in HIV-infected children.

Conference

Study

Authors

Relationships between use of antipsychotics and changes in physical growth in children and adolescents with HIV.

Conference

Authors

Preliminary Pharmacokinetics and Safety of a Novel Pediatric Fixed-Dose Combination (FDC) of Zidovudine (ZDV), Lamivudine (3TC) and Nevirapine (NVP) versus the Liquid Formulations in HIV-Infected Thai Children

Conference

Study

Authors

Tenofovir pharmacokinetics across three tenofovir-based antiretroviral regimens in HIV-infected children and adolescents.

Conference

Authors

Population pharmacokinetics of tenofovir in HIV-infected children and adolescents

Conference

Authors

Lopinavir population pharmacokinetic model and dose simulation predicts rapid increase in exposure for HIV-infected infants initiating therapy at &lt;6 months of age (IMPAACT/PACTG P1030)

Conference

Study

Authors

Lopinavir population pharmacokinetic model and dose simulation predicts rapid increase in exposure for HIV-infected infants initiating therapy at <6 months of age (IMPAACT/PACTG P1030)